Efficacy and security of intermittent repeated levosimendan administration in patients with advanced heart failure: a randomized, double-blind, placebo controlled multicenter trial: LAICA study.
Event: HEART FAILURE 2016
Topic: Acute Heart Failure
Session: Late Breaking Trials I: Focus on acute heart failure
